Latest papers

Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.

Good news for Marburg virus workers.

Ebola virus: unravelling pathogenesis to combat a deadly disease.

[Ebola and Marburg viruses: the humans strike back].

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge.

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

[Training the trainers seminar and analysis of the Ebola virus hemorrhagic fever outbreaks in central Africa from 2001 to 2004. (Brazzaville, Républic of Congo, April 6-8, 2004].

Vaccines against Ebola and Marburg viruses show promise in primate studies.

A single shot against Ebola and Marburg virus.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Conference report - I. Investigating new vaccines: Ebola and HIV: highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?